Shield Therapeutics reports positive results in paediatric trial
1st Oct 2025 13:31
(Alliance News) - Shield Therapeutics PLC on Wednesday noted positive efficacy and tolerance results from in its phase three ferric maltol Fortis trial. Read More
| Price | 7.75p on 15-10-2025 at 18:10:08 |
|---|---|
| Change | -0.15p -1.9% |
| Buy | 8.00p |
| Sell | 7.50p |
| Last Trade: | Sell 63,923.00 at 7.63p |
| Day's Volume: | 545,575 |
| Last Close: | 7.75p |
| Open: | 7.90p |
| ISIN: | GB00BYV81293 |
| Day's Range | 7.75p - 7.90p |
| 52wk Range: | 2.20p - 9.00p |
| Market Capitalisation: | £82.29m |
| VWAP: | 7.743506p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 63,923 | 7.63p | Ordinary |
16:28:01 - 15-Oct-25 |
| Sell* | 60,000 | 7.66p | Ordinary |
16:05:08 - 15-Oct-25 |
| Buy* | 12 | 8.00p | SI Trade |
16:04:17 - 15-Oct-25 |
| Buy* | 214 | 8.00p | SI Trade |
16:04:17 - 15-Oct-25 |
| Sell* | 20,000 | 7.70p | Ordinary |
16:04:02 - 15-Oct-25 |
| Sell* | 45,000 | 7.70p | Ordinary |
16:01:26 - 15-Oct-25 |
| Buy* | 629 | 7.94p | Ordinary |
15:40:41 - 15-Oct-25 |
| Sell* | 32,082 | 7.78p | Ordinary |
15:34:58 - 15-Oct-25 |
| Unknown* | 16,484 | 7.85p | Ordinary |
11:16:04 - 15-Oct-25 |
| Sell* | 754 | 7.70p | SI Trade |
10:54:52 - 15-Oct-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Oct 2025 3:01 pm | RNS | Grant of Share Options to Chief Executive Officer |
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
| 3rd Sep 2025 2:17 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 27th Aug 2025 7:13 am | RNS | Data published -European Journal of Heart Failure |
| 21st Aug 2025 12:06 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 23rd Jul 2025 7:00 am | RNS | Q2 2025 Trading Update |
| 22nd May 2025 5:06 pm | RNS | Result of AGM |